Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new 'revolutionary' therapeutics?
Autor: | Harvima IT; Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland., Harvima RJ; Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. |
---|---|
Jazyk: | angličtina |
Zdroj: | The British journal of dermatology [Br J Dermatol] 2022 Jul; Vol. 187 (1), pp. 6-7. Date of Electronic Publication: 2022 Apr 12. |
DOI: | 10.1111/bjd.21583 |
Databáze: | MEDLINE |
Externí odkaz: |